Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

118.21 

1.71 1.5%

as of May 14 '21

52 Week Range:

104.40 306.72


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 3.95
5.48
5.97
6.39
6.31
6.58
5.98
6.34
9.86
12.76
20.08
growth rate 38.7% 8.9% 7.0% -1.3% 4.3% -9.1% 6.0% 55.5% 29.4% 57.4%
Earnings BIT -17.42
11.48
7.61
3.43
-6.56
5.04
-4.21
36.93
114.89
105.85
1,065.43
growth rate 100.0% -33.7% -54.9% -100.0% 100.0% -100.0% 100.0% 211.1% -7.9% 906.5%
Avg.PE -32.60
66.23
126.58
147.06
-30.73
416.39
416.39
-21,305.00
35.18
34.40
9.82
growth rate 100.0% 91.1% 16.2% -100.0% 100.0% 0.0% -100.0% 100.0% -2.2% -71.5%
ROA -5.92
3.09
1.92
2.88
-1.96
-1.42
-3.47
-1.23
8.52
8.49
58.25
growth rate 100.0% -37.9% 50.0% -100.0% 0.0% 0.0% 0.0% 100.0% -0.4% 586.1%
ROE -9.43
5.12
2.59
3.49
-3.02
-2.62
-6.59
-3.82
22.73
14.80
85.63
growth rate 100.0% -49.4% 34.8% -100.0% 0.0% 0.0% 0.0% 100.0% -34.9% 478.6%
ROIC -6.07
4.17
2.60
3.58
-1.91
0.47
-1.06
0.49
15.88
14.42
77.39
growth rate 100.0% -37.7% 37.7% -100.0% 100.0% -100.0% 100.0% 3,140.8% -9.2% 436.7%
Cur. Ratio 3.55
3.18
3.23
3.27
7.56
7.81
6.71
2.58
1.21
1.77
3.39
growth rate -10.4% 1.6% 1.2% 131.2% 3.3% -14.1% -61.6% -53.1% 46.3% 91.5%
Quick Ratio 1.81
2.31
2.05
1.60
6.47
6.81
5.79
0.80
0.75
1.25
3.02
growth rate 27.6% -11.3% -22.0% 304.4% 5.3% -15.0% -86.2% -6.3% 66.7% 141.6%
Leverage 1.91
1.50
1.21
1.21
1.84
1.86
1.94
4.12
1.89
1.63
1.40
growth rate -21.5% -19.3% 0.0% 52.1% 1.1% 4.3% 112.4% -54.1% -13.8% -14.1%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 13.50
25.33
39.19
38.29
34.47
18.40
24.99
78.36
76.89
102.35
529.17
growth rate 87.6% 54.7% -2.3% -10.0% -46.6% 35.8% 213.6% -1.9% 33.1% 417.0%
Acct.Payable 25.47
13.88
14.44
12.42
8.68
16.05
27.28
25.17
26.70
86.32
growth rate -45.5% 4.0% -14.0% -30.2% 85.0% 70.0% -7.7% 6.1% 223.3%
Cur.Assets 56.00
104.38
74.77
78.62
274.48
240.66
225.39
331.23
193.40
222.23
1,142.40
growth rate 86.4% -28.4% 5.1% 249.1% -12.3% -6.3% 47.0% -41.6% 14.9% 414.1%
Total Assets 214.60
278.89
242.10
271.49
447.41
406.51
388.25
935.25
806.37
910.87
1,871.16
growth rate 30.0% -13.2% 12.1% 64.8% -9.1% -4.5% 140.9% -13.8% 13.0% 105.4%
Cash 6.80
61.33
14.86
9.36
200.90
191.47
169.51
36.09
43.70
52.78
489.94
growth rate 801.9% -75.8% -37.0% 2,047.0% -4.7% -11.5% -78.7% 21.1% 20.8% 828.4%
Inventory 17.70
14.31
15.50
27.64
24.76
26.39
26.05
67.08
67.38
58.09
113.80
growth rate -19.2% 8.3% 78.4% -10.4% 6.6% -1.3% 157.6% 0.5% -13.8% 95.9%
Cur.Liabilities 15.80
32.93
22.50
24.01
36.39
30.83
33.61
128.35
159.74
125.89
336.96
growth rate 108.4% -31.7% 6.7% 51.6% -15.3% 9.0% 281.9% 24.5% -21.2% 167.7%
Liabilities 102.10
93.51
42.32
47.71
202.40
187.83
187.62
708.15
380.79
351.05
538.46
growth rate -8.4% -54.7% 12.7% 324.3% -7.2% -0.1% 277.4% -46.2% -7.8% 53.4%
LT Debt 79.80
47.95
10.57
5.13
137.96
143.30
144.34
377.26
53.19
4.38
0.00
growth rate -39.9% -78.0% -51.5% 2,591.3% 3.9% 0.7% 161.4% -85.9% -91.8% -100.0%
Equity 112.50
185.39
199.78
223.78
245.01
218.68
200.63
227.10
425.58
559.82
1,332.70
growth rate 64.8% 7.8% 12.0% 9.5% -10.8% -8.3% 13.2% 87.4% 31.5% 138.1%
Common Shares 29.00
33.00
34.00
35.00
34.00
34.00
33.00
34.00
43.00
43.00
44.00
growth rate 13.8% 3.0% 2.9% -2.9% 0.0% -2.9% 3.0% 26.5% 0.0% 2.3%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 6.50
4.85
12.22
20.82
11.24
17.03
11.91
17.51
31.69
27.23
64.93
growth rate -25.3% 151.8% 70.4% -46.0% 51.5% -30.1% 47.0% 81.0% -14.1% 138.5%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA -10.21
47.54
19.63
25.68
35.69
36.88
11.82
27.71
136.35
134.49
629.76
growth rate 100.0% -58.7% 30.8% 39.0% 3.4% -68.0% 134.5% 392.1% -1.4% 368.3%
FCF per Share -0.73
0.85
-0.24
0.41
0.18
0.69
-0.05
0.48
1.90
2.38
4.45
growth rate 100.0% -100.0% 100.0% -56.1% 283.3% -100.0% 100.0% 295.8% 25.3% 87.0%
Sale Purchase of Stock 58.62
1.26
5.77
4.78
2.91
8.58
24.89
12.70
4.05
-38.28
growth rate -97.9% 359.1% -17.2% -39.1% 194.6% 190.2% -49.0% -68.1% -100.0%
FCF -21.00
26.00
-8.00
3.00
24.00
19.00
-0.09
10.00
105.00
107.00
565.00
growth rate 100.0% -100.0% 100.0% 700.0% -20.8% -100.0% 100.0% 950.0% 1.9% 428.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 113.30
158.60
155.74
177.33
184.16
194.03
191.60
277.74
522.29
534.89
1,661.67
growth rate 40.0% -1.8% 13.9% 3.9% 5.4% -1.3% 45.0% 88.1% 2.4% 210.7%
Op.Income -15.30
7.63
4.99
7.39
-6.56
5.04
-4.21
36.93
114.89
105.85
1,065.43
growth rate 100.0% -34.6% 48.0% -100.0% 100.0% -100.0% 100.0% 211.1% -7.9% 906.5%
IBT -17.40
11.48
7.61
3.43
-10.98
-9.30
-16.20
-8.04
63.38
77.18
1,040.32
growth rate 100.0% -33.7% -54.9% -100.0% 0.0% 0.0% 0.0% 100.0% 21.8% 1,248.0%
Net Income -11.30
7.63
4.99
7.39
-7.07
-6.08
-13.81
-8.17
74.18
72.92
810.29
growth rate 100.0% -34.6% 48.0% -100.0% 0.0% 0.0% 0.0% 100.0% -1.7% 1,011.2%
EPS -0.39
0.23
0.15
0.21
-0.21
-0.18
-0.42
-0.24
1.86
1.73
18.60
growth rate 100.0% -34.8% 40.0% -100.0% 0.0% 0.0% 0.0% 100.0% -7.0% 975.1%
Gross Profit 60.70
95.74
94.46
110.35
109.07
118.01
111.25
167.01
319.36
320.81
1,348.86
growth rate 57.7% -1.3% 16.8% -1.2% 8.2% -5.7% 50.1% 91.2% 0.5% 320.5%
R&D 23.70
26.33
27.72
34.19
37.91
35.51
38.67
33.64
51.65
52.55
84.29
growth rate 11.1% 5.3% 23.3% 10.9% -6.3% 8.9% -13.0% 53.5% 1.8% 60.4%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 35.06
53.54
84.54
308.35
618.15
growth rate 52.7% 57.9% 264.8% 100.5%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 94.50
110.79
120.42
376.13
529.17
growth rate 17.2% 8.7% 212.4% 40.7%
Acct.Payable 43.99
33.15
37.47
49.37
86.32
growth rate -24.6% 13.0% 31.8% 74.8%
Cur.Assets 222.23
286.48
296.94
560.94
1,142.40
growth rate 28.9% 3.7% 88.9% 103.7%
Total Assets 806.37
966.77
972.93
1,249.36
1,871.16
growth rate 19.9% 0.6% 28.4% 49.8%
Cash 52.78
108.77
72.59
77.55
489.94
growth rate 106.1% -33.3% 6.8% 531.8%
Inventory 58.09
58.71
92.62
95.22
113.80
growth rate 1.1% 57.8% 2.8% 19.5%
Cur.Liabilities 159.74
136.20
182.98
207.89
336.96
growth rate -14.7% 34.4% 13.6% 62.1%
Liabilities 182.30
361.57
361.22
400.11
538.46
growth rate 98.3% -0.1% 10.8% 34.6%
LT Debt 4.38
growth rate
Equity 559.82
605.20
611.71
849.25
1,332.70
growth rate 8.1% 1.1% 38.8% 56.9%
Common Shares 43.29
0.04
0.04
0.04
0.04
growth rate -99.9% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 8.51
5.88
7.50
22.72
28.82
growth rate -30.9% 27.5% 202.8% 26.8%
Cash Dividends
growth rate
Cash From OA 47.72
61.18
59.00
70.46
439.13
growth rate 28.2% -3.6% 19.4% 523.3%
Sale Purchase of Stock -7.20
0.85
-39.61
0.35
0.13
growth rate 100.0% -100.0% 100.0% -62.2%
FCF 39.21
55.30
51.49
47.73
410.32
growth rate 41.0% -6.9% -7.3% 759.6%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 165.17
174.65
201.75
476.06
809.20
growth rate 5.7% 15.5% 136.0% 70.0%
Op.Income 35.06
53.54
84.54
308.35
618.15
growth rate 52.7% 57.9% 264.8% 100.5%
IBT 32.51
48.82
80.20
295.78
615.52
growth rate 50.2% 64.3% 268.8% 108.1%
Net Income 30.63
40.24
67.65
232.27
470.13
growth rate 31.4% 68.1% 243.3% 102.4%
EPS
growth rate
Gross Profit 94.84
114.99
148.75
383.62
701.49
growth rate 21.3% 29.4% 157.9% 82.9%
R&D 14.92
16.38
20.97
21.45
25.50
growth rate 9.8% 28.0% 2.3% 18.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (90.40)

YOY Growth Grade:

D (44.31)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 6.36 5.44 10.29
EPS / Growth 39.6% 21.74 7.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.2% 32.3% 33.6%
Future PE 6.36 8.98 27.96
Future EPS 43.57 356.35 394.14
Value Price
MOS %
68.50
-42.1%
790.88
569.0%
2,723.62
2,204.0%
MOS Price 34.25 395.44 1,361.81
IRT 4.47 3.02 2.97

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.